Best Value Stocks to Buy Top Value Stocks with Strong Buy Rank for February 7th

Daily Market Recaps (no fluff)

always free

Heading into February 7, investors are eyeing three stocks with buy rank and robust value characteristics, each deserving a closer look.

Investment and Trading Gem: Mitsui & Co., Ltd. (MITSY)

Mitsui & Co., Ltd., an investment and trading company, boasts a Zacks Rank #1. What’s more, the Zacks Consensus Estimate for its current year earnings has surged 4.8% over the last 60 days.

Mitsui & Co. Price and Consensus

Mitsui & Co., Ltd. flaunts a price-to-earnings ratio (P/E) of 8.84, well below the industry’s average of 21.60. With a Value Score of A, this company is surely a diamond in the rough.

Diversified Retail and Financial Services Ace: J Sainsbury plc (JSAIY)

J Sainsbury plc, a diversified retail and financial services company, holds a Zacks Rank #1. Moreover, the Zacks Consensus Estimate for its current year earnings has climbed 2% over the last 60 days.

J. Sainsbury PLC Price and Consensus

With a price-to-earnings ratio (P/E) of 13.72, compared with the industry’s 14.00, J Sainsbury plc is not only a bargain but also scores an A in terms of value.

Pharma Powerhouse: Bausch Health Companies Inc. (BHC)

Bausch Health Companies Inc., a pharmaceutical company, carries a Zacks Rank #1. Even more remarkable is the fact that the Zacks Consensus Estimate for its next year earnings has powered up 2.9% over the last 60 days.

Bausch Health Cos Inc. Price and Consensus

With a price-to-earnings ratio (P/E) of 2.00, compared with the S&P average of 21.97, Bausch Health Companies Inc. has an A in value, making it a standout in the pharmaceutical space.

For the full list of top-ranked stocks, visit Zacks. To better understand the value score and how it’s calculated, check out Zacks’ education resource.

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts have chosen their favorite to potentially skyrocket +100% or more in months to come. According to the Director of Research Sheraz Mian, it’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients. Now is the time to catch this timely investment, emerging from its bear market lows. It could rival or surpass other recent Stocks Set to Double such as Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Mitsui & Co. (MITSY) : Free Stock Analysis Report

J. Sainsbury PLC (JSAIY) : Free Stock Analysis Report

Bausch Health Cos Inc. (BHC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Do you want a daily market summary with no fluff?

Simple Straightforward Daily Stock Market Recaps Sent for free,every single trading day: Read Now

Explore More

Simple Straightforward Daily Stock Market Recaps

Get institutional-level analysis to take your trading to the next level, sign up for free and become apart of the community.